Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1976-3-20
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0026-895X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
751-8
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1207672-Adenosine Diphosphate,
pubmed-meshheading:1207672-Humans,
pubmed-meshheading:1207672-Imidazoles,
pubmed-meshheading:1207672-Magnetic Resonance Spectroscopy,
pubmed-meshheading:1207672-Nitrofurantoin,
pubmed-meshheading:1207672-Platelet Aggregation,
pubmed-meshheading:1207672-Quantum Theory
|
| pubmed:year |
1975
|
| pubmed:articleTitle |
The molecular components of nitrofurantoin critical to its inhibitory effect upon platelet aggregation.
|
| pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|